Blog

Events

Resources

Education

Patient Views During the CTV Renaissance

  • DeepIntent
  • 8-16-2022

CTV is changing how advertising is targeted, sold, and delivered, but how do patients feel about the new technology? Unlike smartphones and tablets, CTV hasn’t required people to become comfortable with new technology; the ads are delivered on the same TV sets people have known forever. We conducted research exploring whether patients understand that they’re in the middle of a media renaissance and how they feel about it as it pertains to pharma ads.

John Mangano, DeepIntent’s SVP of Analytics, presents the key findings from this research, with specific insight into:

+  How patients view pharma ads on linear TV vs. CTV
+  How valuable they find pharma advertising in general
+  How their viewing behaviors reflect wider viewing trends

Share this Post

Related Articles

AdLab Recap: How Innovation and Interoperability Will Enable Personalized Advertising

As health marketing undergoes rapid disruption around privacy and identity, delivering personalized messaging at scale becomes a steeper challenge—and an even more important goal. It isn’t just about “selling” more products. It’s about finding new ways to reach people and improve health outcomes. At AdLab Health Marketing Summit, DeepIntent Founder and CEO Chris Paquette urged […]

  • DeepIntent
  • 5-10-2024
Read More

Revolutionizing Healthcare Advertising: How DeepIntent Outcomes™ Delivers Exceptional Performance for Leading Pharma Brands

Proven to drive audience quality (AQ) and script lift, DeepIntent Outcomes™ is the industry’s fastest measurement solution based on clinical data. Download our eBooklet for a look at how Outcomes helped some of the leading pharma brands achieve: 164% higher audience quality over the course of a campaign 27% higher script lift within the first […]

  • DeepIntent
  • 5-25-2023
Read More

Silver Streamers: A Golden Opportunity for Pharma Advertisers on CTV

With the rapid rise of streaming in recent years, it’s a common misconception that older audiences are still spending the majority of their viewing time with linear TV — a belief that has kept most pharma advertising investments focused on traditional channels. As one of the most important demographics for pharma, we set out to […]

  • DeepIntent
  • 5-10-2023
Read More

Never Miss New Insights

Sign up for the newsletter to ensure our latest whitepapers, research reports, and more are delivered to your inbox.

Subscribe